I. Fusier

Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience

François Bocquet, Pascal Paubel, I. Fusier et al. · Applied Health Economics and Health Policy · 2014 · 23 citations

Engineering, Hematology, Translational Research +4

Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis

François Bocquet, Pascal Paubel, I. Fusier et al. · Applied Health Economics and Health Policy · 2014 · 23 citations

Granulocyte, Hematology, Biostatistics +2

Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience

François Bocquet, A Loubière, I. Fusier et al. · PharmacoEconomics · 2016 · 17 citations

Biologic Agent, Engineering, Research Commercialization +14

Infovigilance: Reporting Errors in Official Drug Information Sources

I. Fusier, Corinne Tollier, Marie‐Caroline Husson · Pharmacy World & Science · 2005 · 13 citations

Drug Safety, Health Policy, Drug Information System +6